Neirg Wealth Management, LLC Gilead Sciences, Inc. Transaction History

Neirg Wealth Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 31, 2023	BUY	$76.01 - $86.7 $5,092 - $5,808	67 Added 2.36%	2,908 $224,000
Q1 2023 May 04, 2023	BUY	$77.31 - $88.08 $219,637 - $250,235	2,841 New	2,841 $235,000
Q1 2022 May 11, 2022	SELL	$57.92 - $72.58 $582,501 - $729,937	-10,057 Closed	0 $0
Q4 2021 Feb 07, 2022	BUY	$64.88 - $73.64 $652,498 - $740,597	10,057 New	10,057 $730,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Neirg Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Neirg Wealth Management, LLC with notifications on news.